Approval · United States
Rybelsus
U.S. Food and Drug Administration · Sep 20, 2019
Approval record
- Asset
- Oral semaglutide
- Brand name
- Rybelsus
- Generic name
- semaglutide
- Indication
- Type 2 diabetes
- Jurisdiction
- United States
- Regulator
- U.S. Food and Drug Administration
- Approval date
- Sep 20, 2019
- Company
- Novo Nordisk
Sources
- regulatoryprimary record
FDA approves Wegovy (semaglutide) for chronic weight management
U.S. Food and Drug Administration · FDA News Release · Jun 4, 2021